Pharmacist Infectious Disease | Standard of Care | Treatment Guidelines Podcast 30 credit minutes

Corticosteroids in the treatment of community-acquired pneumonia (CAP) remain a topic of clinical curiosity and mixed opinions. In this unique episode, two expert guests share opposing perspectives—one advocating for corticosteroid use in CAP and the other urging caution—offering pharmacists a balanced view of the current evidence and practice considerations. Tune in to explore both sides of the debate and walk away with insights to inform your role in collaborative patient care.

Available in Subscription

This course is included in the following subscription:

Pharmacist CE Subscription

Pharmacist CE Subscription

Renewed Annually
$99.00 / year

Learning Objectives

Upon successful completion of this course, pharmacists should be able to:
1. Describe current evidence supporting and challenging the use of corticosteroids in the treatment of community-acquired pneumonia (CAP).
2. Identify key considerations for pharmacists when evaluating corticosteroid use as adjunctive therapy in CAP.

Faculty

Rachel Maynard, PharmD

Disclosures:

Rachel Maynard has no relevant financial relationships to disclose.

Sam Markle, PharmD

Disclosures:

Sam Markle has no relevant financial relationships to disclose.

Tristan Houle, PharmD

Disclosures:

Tristan Houle has no relevant financial relationships to disclose.

Course Details